Toxicity, response, and survival in older adults with metastatic melanoma treated with checkpoint inhibitors.

Authors

null

Nienke A De Glas

Leiden University Medical Center, Leiden, Netherlands

Nienke A De Glas , Esther Bastiaannet , Frederiek van den Bos , Simon Mooijaart , Astrid Aplonia Maria Van Der Veldt , Karijn Suijkerbuijk , Maureen J.B. Aarts , Franchette van den Berkmortel , Christian U. Blank , Marye Boers-Sonderen , Alfonsus Johannes Maria van den Eertwegh , Jan Willem de Groot , Geke Hospers , John B. A. G. Haanen , Djura Piersma , Rozemarijn Van Rijn , A. J. Ten Tije , Michel W.J.M. Wouters , Johanna Elisabeth A. Portielje , Ellen Kapiteijn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Advanced/Metastatic Disease

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 9544)

DOI

10.1200/JCO.2021.39.15_suppl.9544

Abstract #

9544

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2019 ASCO-SITC Clinical Immuno-Oncology Symposium

Autoimmune toxicities with anti-PD-1 treatment of metastatic melanoma in predominantly older patients: A single institutional experience.

Autoimmune toxicities with anti-PD-1 treatment of metastatic melanoma in predominantly older patients: A single institutional experience.

First Author: Harsh V Parmar

First Author: Christoffer Gebhardt

First Author: Thierry Landre

First Author: Jessica Heejin Yoo